Skip to main content
. 2019 Nov 22;9:17417. doi: 10.1038/s41598-019-53870-3

Figure 6.

Figure 6

Effect of ROX plus siVEGF/siFlk1 on B16F10 xenograft growth. The tumor volume (a) and weight (b) of the B16F10 xenografts at 7 days of treatment. *P < 0.05 vs. PBS control; #P < 0.05, ##P < 0.01 vs. 5 mg/kg ROX. (c) HE staining analysis of B16F10 tumor tissue; scale bar = 100 μm.